CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

CASI Pharmaceuticals (CASIF) Total Debt (2023 - 2026)

Updated

CASI Pharmaceuticals' Total Debt came in at $21.25 million for Q2 2026.

Analysis

CASI Pharmaceuticals (CASIF) Total Debt (2023 - 2026) Analysis & Trends

At the end of FY2025, CASI Pharmaceuticals' Total Debt was $20.19 million, up 9.8% from FY2024.

  • Going back by year, Total Debt was $18.39 million in FY2024 (-2.7%) and $18.9 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 CASI Pharmaceuticals 2.06 Mn -18.77 Mn - 21.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.25 Mn
Dec 31, 2025 20.19 Mn
Dec 31, 2024 18.39 Mn
Sep 30, 2024 19.12 Mn
Jun 30, 2024 18.47 Mn
Mar 31, 2024 18.59 Mn
Dec 31, 2023 18.90 Mn
API Access

CASI Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=CASIF&period=max&api_key=YOUR_API_KEY